Acquired Hemophilia in Pediatric Population.
نویسندگان
چکیده
The development of acquired inhibitors against the factor VIII protein in childhood period, is a very rare disorder in nonhemophiliac persons but may be clinically important condition due to potential serious bleedings. We have investigated acquired hemophilia development frequency in children with potential high risk groups. Totally 483 nonhemophiliac children including healthy controls were enrolled the study. Age range was 2 to 20 years and mean age was 11 ± 5.4 years. Risk groups for acquired hemophilia were selected among sick children with transfusion dependent ß- thalassemia major (n= 75), children with malignancy (n= 55), asthma bronchiale (n= 65), type I insulin dependent diabetes mellitus (n= 63), collagen tissue disorders (n= 35). Age-matched 190 healthy children were selected as for healthy control group. Inhibitor tests were performed by the method of Bethesda assay. We have found only two patients who had acquired factor VIII inhibitor among 483 children. These two patients were solid tumor (osteosarcoma) and type I insulin dependent diabetes mellitus. Other risk groups and healthy controls have not inhibitor positivity. As a conclusion, acquired inhibitors should be considered for the differential diagnosis of unusual bleeding episodes in patients who had risk factors of all age groups including childhood period.
منابع مشابه
Assessment of the Prevalence of Hepatitis C and B Viruses in Patients with Hemophilia in Qom Province, (Iran)
Background and Objectives: Hemophilia is a hereditary bleeding disorder, which CFC (clotting factor concentration) method is used for prevention and treatment of about 70% of these patients. This method can play an important role in the transmission of blood-borne viruses, such as hepatitis B and C. According to studies, more than 40% of patients with hemophilia have one of the hepatitis C, B, ...
متن کاملFrom the Center for Bloodless Medicine and Surgery Children's Hospital Central California
To date, the majority of experience with recombinant factor VIIa (rFVIIa) has been in patients with hemophilia who developed autoantibodies (inhibitors) against factor VIII. This paper examines the reported experiences with rFVIIa use in non-hemophiliac pediatric-aged patients and is based on a review of the literature as well as an evaluation of isolated case reports and case series. The liter...
متن کاملHemophilic Pseudotumor of Humerus in an Adolescent with Severe Hemophilia A
This article has no abstract.
متن کاملHereditary Angioedema: Moving Therapy into the Home and to Self-Care
Hereditary angioedema (HAE) is a condition that results in recurrent and often unpredictable attacks of angioedema, which is associated with significant morbidity and can be fatal. The majority of literature related to management of HAE has focused on the adult patient. There is limited information on treatment and management strategies for the pediatric HAE population. Comprehensive care has b...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Turkish journal of haematology : official journal of Turkish Society of Haematology
دوره 19 2 شماره
صفحات -
تاریخ انتشار 2002